戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nown whether such an association exists with Cryptococcus neoformans.
2 for virulence of the human pathogenic fungus Cryptococcus neoformans.
3 th a similar function in the related species Cryptococcus neoformans.
4 mall-RNA biogenesis in the pathogenic fungus Cryptococcus neoformans.
5 ual development of the human fungal pathogen Cryptococcus neoformans.
6 ntainment following pulmonary challenge with Cryptococcus neoformans.
7  C57BL/6 mice after pulmonary infection with Cryptococcus neoformans.
8 pC) and with the LPMO-like protein Bim1 from Cryptococcus neoformans.
9 hose for the pathogens, Candida albicans and Cryptococcus neoformans.
10  involved in polysaccharide O-acetylation in Cryptococcus neoformans.
11 haromyces cerevisiae, Malassezia furfur, and Cryptococcus neoformans.
12 illness caused by the opportunistic pathogen Cryptococcus neoformans.
13 ts (MC) arising from phenotypic switching of Cryptococcus neoformans.
14 transgene array in the human fungal pathogen Cryptococcus neoformans.
15  prolongs the survival of mice infected with Cryptococcus neoformans.
16 ghest prevalence of coinfection with HIV and Cryptococcus neoformans.
17 e host survival of the human fungal pathogen Cryptococcus neoformans.
18 al3b (CNAG_07348) from the pathogenic fungus Cryptococcus neoformans.
19 tic cells (DC) during their interaction with Cryptococcus neoformans.
20 ssociated trait by the human fungal pathogen Cryptococcus neoformans.
21 nt role in protection against infection with Cryptococcus neoformans.
22 osis induced by intratracheal inoculation of Cryptococcus neoformans.
23 T cell responses to the opportunistic fungus Cryptococcus neoformans.
24 l time of mice infected intracerebrally with Cryptococcus neoformans.
25 nt role in immunity to the pathogenic fungus Cryptococcus neoformans.
26  Candida species, Aspergillus fumigatus, and Cryptococcus neoformans.
27 sponse to infection with the fungal pathogen Cryptococcus neoformans.
28 nsing pathway in the human pathogenic fungus Cryptococcus neoformans.
29 t regulates virulence in the fungal pathogen Cryptococcus neoformans.
30 IP5/IP7, which is essential for virulence of Cryptococcus neoformans.
31  central role in regulating the virulence of Cryptococcus neoformans.
32 d with the distantly related fungal pathogen Cryptococcus neoformans.
33  of H3K27 methylation (H3K27me) in the yeast Cryptococcus neoformans.
34 genes in bacteria [16], and mating events in Cryptococcus neoformans[14, 17].
35 cosis following intratracheal inoculation of Cryptococcus neoformans 24067.
36 a spp., 146 from 9 Aspergillus spp., 84 from Cryptococcus neoformans, 40 from 23 other mold species,
37 nfected with a moderately virulent strain of Cryptococcus neoformans (52D), which resulted in prolong
38 trophils have been shown to efficiently kill Cryptococcus neoformans, a causative agent of meningoenc
39                         Human infection with Cryptococcus neoformans, a common fungal pathogen, follo
40 c functional analysis of the phosphatases in Cryptococcus neoformans, a fungal pathogen that causes l
41                This is particularly true for Cryptococcus neoformans, a human fungal pathogen that ca
42                    Here, we demonstrate that Cryptococcus neoformans, a model eukaryotic pathogen, re
43                         One such organism is Cryptococcus neoformans, a pathogenic yeast that causes
44         It has shown potent activity against Cryptococcus neoformans, a yeast that can affect immunoc
45                        The pathogenic fungus Cryptococcus neoformans additionally anchors its polysac
46                                              Cryptococcus neoformans admissions were not seasonal, an
47 es for melanization of the pathogenic fungus Cryptococcus neoformans also offers unique opportunities
48 ulates not only mating but also virulence in Cryptococcus neoformans, an opportunistic human pathogen
49  the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp.
50 d specificity were as follows: 100% each for Cryptococcus neoformans and C. gattii, 98.6% and 100% fo
51 ally expressed by the four main serotypes of Cryptococcus neoformans and C. gattii, is heterogeneousl
52 Aspergillus fumigatus, Alternaria alternata, Cryptococcus neoformans and Candida albicans) proteins w
53 inent function in the capture of circulating Cryptococcus neoformans and Candida albicans, thereby re
54 e of macrophage autophagy in the response to Cryptococcus neoformans and Candida albicans, two import
55 ectivity for the Hsp90 isoforms expressed by Cryptococcus neoformans and Candida albicans, two pathog
56 nse against two prototypic fungal pathogens, Cryptococcus neoformans and Candida albicans.
57 ns (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioides immitis).
58                                              Cryptococcus neoformans and Cryptococcus gattii are clos
59                                              Cryptococcus neoformans and Cryptococcus gattii are clos
60                                              Cryptococcus neoformans and Cryptococcus gattii are two
61              Fundamental niche prediction of Cryptococcus neoformans and Cryptococcus gattii in Europ
62 ompare the molecular genotypes of strains of Cryptococcus neoformans and Cryptococcus gattii isolated
63 marily caused by two related fungal species: Cryptococcus neoformans and Cryptococcus gattii.
64 Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii.
65 poxia-mimetic CoCl2 in the pathogenic fungus Cryptococcus neoformans and demonstrated that CoCl2 lead
66 rabidopsis thaliana, Caenorhabditis elegans, Cryptococcus neoformans and Drosophila melanogaster.
67 Rho-GDI homolog in the human fungal pathogen Cryptococcus neoformans and investigated its impact on p
68 erol endoperoxide, which were active against Cryptococcus neoformans and methicillin-resistance Staph
69 +) channel present in the plasma membrane of Cryptococcus neoformans and other fungi.
70 H)2) cell bias upon pulmonary infection with Cryptococcus neoformans and other non-T(H)2 stimuli.
71 in GM-CSF are susceptible to infections with Cryptococcus neoformans and other opportunistic fungi.
72 ons against Candida albicans, Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus (Sigm
73       The fungal pathogens Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus have
74 sential for virulence of the fungal pathogen Cryptococcus neoformans, and bacterial P5CDHs have been
75 heromone responses, mating, and virulence in Cryptococcus neoformans, and it also reiterates that the
76 hly active against a second fungal pathogen, Cryptococcus neoformans, and moderately active against a
77 ntamoeba histolytica, Trichomonas vaginalis, Cryptococcus neoformans, and Saccharomyces cerevisiae us
78                      Cryptococcus gattii and Cryptococcus neoformans are causal agents of cryptococco
79    However, pathogenic strains of the fungus Cryptococcus neoformans are resistant to MBL binding.
80 gh activity toward Aspergillus fumigatus and Cryptococcus neoformans at acidic pH, yet remained nonto
81 e infections with pathogenic species such as Cryptococcus neoformans Because the purine biosynthesis
82                               Infection with Cryptococcus neoformans begins when desiccated yeast cel
83 se, and catalytically dead Tps2PD(D24N) from Cryptococcus neoformans bound to trehalose-6-phosphate (
84 can is a major component of the cell wall of Cryptococcus neoformans, but its function has not been i
85 ved (Blastomyces dermatitidis by culture and Cryptococcus neoformans by PLEX-ID).
86                                              Cryptococcus neoformans (C. neoformans var. grubii) is a
87               Upon ingestion by macrophages, Cryptococcus neoformans can survive and replicate intrac
88 rated that the opportunistic fungal pathogen Cryptococcus neoformans can synthesize authentic immunom
89 ificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and foun
90                                              Cryptococcus neoformans capsular polysaccharides glucuro
91                                              Cryptococcus neoformans causes life-threatening meningit
92                                              Cryptococcus neoformans causes life-threatening meningoe
93                      The opportunistic yeast Cryptococcus neoformans causes serious disease in humans
94                                              Cryptococcus neoformans causes severe, and often fatal,
95 xin, Srx1, in oxidative stress resistance of Cryptococcus neoformans causing fungal meningoencephalit
96 n macrophages that had ingested live or dead Cryptococcus neoformans cells, or inert beads.
97                                        As in Cryptococcus neoformans, cellular trehalose was reduced
98                                 In the yeast Cryptococcus neoformans, CG methylation occurs in transp
99 rain - is a recently described phenomenon in Cryptococcus neoformans (Cn) and Cryptococcus gattii (Cg
100                                              Cryptococcus neoformans (Cn) is a common facultative int
101                                              Cryptococcus neoformans (Cn) is a deadly fungal pathogen
102 tudies, we showed that the pathogenic fungus Cryptococcus neoformans (Cn) produces a specific and uni
103 iodiomycete forming an induced DOPA-melanin, Cryptococcus neoformans (CN); and the slow-growing envir
104       Here, we focus on the Prp8 intein from Cryptococcus neoformans (Cne), a human fungal pathogen.
105                                           On Cryptococcus neoformans, configuring Conrad to reproduce
106 D82 showed rapid and specific recruitment to Cryptococcus neoformans-containing phagosomes compared t
107 ith Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma ca
108                       Molecular types of the Cryptococcus neoformans/Cryptococcus gattii species comp
109 an parechovirus, varicella-zoster virus, and Cryptococcus neoformans/Cryptococcus gattii We describe
110         The role of B cells in resistance to Cryptococcus neoformans disease (i.e., cryptococcosis) i
111 l-deficient mice have demonstrated increased Cryptococcus neoformans dissemination from lungs to brai
112 aride capsule of the human pathogenic fungus Cryptococcus neoformans elicit diverse effects on fungal
113                    The human fungal pathogen Cryptococcus neoformans encodes many Cu-responsive genes
114                       The immune response to Cryptococcus neoformans following pulmonary infection of
115                                              Cryptococcus neoformans frequently causes fungal meningi
116 e expulsion of the lethal endosomal pathogen Cryptococcus neoformans from mammalian macrophages, also
117            Eumelanins produced by pathogenic Cryptococcus neoformans fungi are virulence factors that
118 he pathogenicity of a human fungal pathogen, Cryptococcus neoformans, GCS1 is not required for the pa
119 evealed apparent specificity differences for Cryptococcus neoformans glucuronoxylomannan (GXM).
120  AfTOK1 (Aspergillus fumigatus), and H99TOK (Cryptococcus neoformans grubii) are K(+) -selective and
121 ed the role of a Th2 bias in pathogenesis of Cryptococcus neoformans H99 infection by comparing inhal
122                  The human pathogenic fungus Cryptococcus neoformans has a distinctive polysaccharide
123                  The human pathogenic fungus Cryptococcus neoformans has a large polysaccharide capsu
124                                 Furthermore, Cryptococcus neoformans has become a primary human patho
125                                   The fungus Cryptococcus neoformans has emerged as a major cause of
126 ot been studied in the human fungal pathogen Cryptococcus neoformans Here, we identified and characte
127 n of clinically significant Candida species, Cryptococcus neoformans, Histoplasma capsulatum, and Bla
128 nistic fungal pathogens Candida albicans and Cryptococcus neoformans However, the molecular mechanism
129 ction with the opportunistic fungal pathogen Cryptococcus neoformans; however, the role of plasmacyto
130        Recent studies in the pathobiology of Cryptococcus neoformans identified the presence of a fun
131 e mAbs to the capsule of the fungal pathogen Cryptococcus neoformans impaired yeast budding by trappi
132          Persistent pulmonary infection with Cryptococcus neoformans in C57BL/6 mice results in chron
133                                The burden of Cryptococcus neoformans in cerebrospinal fluid (CSF) pre
134 he development of the protective response to Cryptococcus neoformans in mice with cryptococcal pneumo
135 ts for different levels of susceptibility to Cryptococcus neoformans in the mouse infection model.
136                  However, it is not known if Cryptococcus neoformans-induced changes in lung function
137                       Experimental pulmonary Cryptococcus neoformans infection in BALB/c mice is asso
138 e highly susceptible to intratracheal (i.t.) Cryptococcus neoformans infection relative to BALB/c mic
139 ing the risk of dissemination and outcome of Cryptococcus neoformans infection were assessed in 111 o
140 cterium tuberculosis, Toxoplasma gondii, and Cryptococcus neoformans infection, implicating inflammat
141 tes transmigration of the neurotropic fungus Cryptococcus neoformans into the brain parenchyma after
142                      The mechanisms by which Cryptococcus neoformans invades the brain are largely un
143                       The mechanism by which Cryptococcus neoformans invades the central nervous syst
144                                              Cryptococcus neoformans is a basidiomycete fungus that i
145                                              Cryptococcus neoformans is a basidiomycete fungus that i
146               The fungal meningitis pathogen Cryptococcus neoformans is a central driver of mortality
147                      The encapsulated fungus Cryptococcus neoformans is a common cause of life-threat
148          Lethal disease caused by the fungus Cryptococcus neoformans is a consequence of the combined
149                                              Cryptococcus neoformans is a facultative intracellular f
150                                              Cryptococcus neoformans is a facultative intracellular o
151                                              Cryptococcus neoformans is a facultative intracellular p
152                                              Cryptococcus neoformans is a fatal fungal pathogen of hu
153                                              Cryptococcus neoformans is a fungal pathogen causing pul
154                                              Cryptococcus neoformans is a fungal pathogen that causes
155                                              Cryptococcus neoformans is a fungal pathogen that causes
156                                              Cryptococcus neoformans is a fungal pathogen that causes
157                                              Cryptococcus neoformans is a fungal pathogen that encoun
158                                              Cryptococcus neoformans is a fungal pathogen that kills
159                                              Cryptococcus neoformans is a fungal pathogen with a uniq
160                                              Cryptococcus neoformans is a fungal pathogen with worldw
161                                              Cryptococcus neoformans is a global human fungal pathoge
162                                              Cryptococcus neoformans is a human fungal pathogen that
163                                              Cryptococcus neoformans is a human fungal pathogen that
164                                              Cryptococcus neoformans is a human fungal pathogen that
165                                              Cryptococcus neoformans is a human fungal pathogen that
166                     The basidiomycete fungus Cryptococcus neoformans is a leading cause of AIDS-relat
167                                   The fungus Cryptococcus neoformans is a leading cause of mortality
168                                              Cryptococcus neoformans is a neurotropic fungal pathogen
169                                              Cryptococcus neoformans is a pathogenic fungus responsib
170                                              Cryptococcus neoformans is a pathogenic yeast capable of
171                                              Cryptococcus neoformans is a pathogenic yeast that can i
172                                              Cryptococcus neoformans is a pathogenic yeast that cause
173                       The encapsulated yeast Cryptococcus neoformans is a significant cause of mening
174                                              Cryptococcus neoformans is a significant fungal pathogen
175                                              Cryptococcus neoformans is a ubiquitous environmental fu
176                                              Cryptococcus neoformans is a ubiquitous, opportunistic f
177          The basidiomycetous fungal pathogen Cryptococcus neoformans is adapted to survive challenges
178  The SREBP ortholog in the pathogenic fungus Cryptococcus neoformans is also activated by high levels
179                                              Cryptococcus neoformans is an encapsulated fungal pathog
180                                              Cryptococcus neoformans is an encapsulated fungal pathog
181                                              Cryptococcus neoformans is an encapsulated fungus that c
182                                              Cryptococcus neoformans is an encapsulated human-pathoge
183                                              Cryptococcus neoformans is an encapsulated opportunistic
184                                              Cryptococcus neoformans is an environmental pathogen req
185                                              Cryptococcus neoformans is an important human, fungal pa
186                                              Cryptococcus neoformans is an opportunistic fungal patho
187                                              Cryptococcus neoformans is an opportunistic fungal patho
188                                              Cryptococcus neoformans is an opportunistic fungal patho
189                                              Cryptococcus neoformans is an opportunistic fungal patho
190                                              Cryptococcus neoformans is an opportunistic fungal patho
191                                              Cryptococcus neoformans is an opportunistic fungal patho
192                                              Cryptococcus neoformans is an opportunistic fungal patho
193                                              Cryptococcus neoformans is an opportunistic fungal patho
194                                              Cryptococcus neoformans is an opportunistic fungal patho
195                                              Cryptococcus neoformans is an opportunistic human pathog
196                                              Cryptococcus neoformans is an opportunistic pulmonary fu
197                                              Cryptococcus neoformans is an opportunistic yeast that i
198                                              Cryptococcus neoformans is an unconventional dimorphic f
199 ity to progressive infection with the fungus Cryptococcus neoformans is associated with an allergic p
200 pulmonary infection with the fungal pathogen Cryptococcus neoformans is associated with the accumulat
201 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans is associated with the CCR2-medi
202                                   The fungus Cryptococcus neoformans is currently the fourth greatest
203                                              Cryptococcus neoformans is ecologically widespread and a
204 the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether
205                      The opportunistic yeast Cryptococcus neoformans is surrounded by a polysaccharid
206                                              Cryptococcus neoformans is the leading cause of death by
207                                              Cryptococcus neoformans is the most common cause of adul
208                                              Cryptococcus neoformans is the only encapsulated human-p
209 d trait of the opportunistic fungal pathogen Cryptococcus neoformans is the production of melanin pig
210     The manifestation of virulence traits in Cryptococcus neoformans is thought to rely on intracellu
211 relevant yeast species (Candida glabrata and Cryptococcus neoformans), is shown.
212 hannel from the model human fungal pathogen, Cryptococcus neoformans, is directly activated by the de
213 l pathogens of environmental origin, such as Cryptococcus neoformans, is their ability to adapt to ma
214 mune response against the pathogenic fungus, Cryptococcus neoformans, is unknown.
215 9%) Candida tropicalis isolates and 1 (2.4%) Cryptococcus neoformans isolate.
216 andida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infe
217 es, 15 isolates of the Zygomycetes order, 10 Cryptococcus neoformans isolates, 8 Rhodotorula isolates
218  C. glabrata, and 53 C. krusei isolates), 35 Cryptococcus neoformans isolates, and 191 other clinical
219 virulence factor laccase to the cell wall in Cryptococcus neoformans Laccase activity was perturbed,
220                                  Compared to Cryptococcus neoformans, little is known about the virul
221 e fungal pathogens Aspergillus fumigatus and Cryptococcus neoformans, little was known about their in
222  Pathogens included Balamuthia mandrillaris, Cryptococcus neoformans, lymphocytic choriomeningitis vi
223 on doubled the time-to-endpoint of mice with Cryptococcus neoformans meningitis.
224 Isavuconazole showed good activities against Cryptococcus neoformans (MIC90, 0.12 mug/ml) and other n
225      Numerous virulence factors expressed by Cryptococcus neoformans modulate host defenses by promot
226 rable to infection by the encapsulated yeast Cryptococcus neoformans Most commonly found in the envir
227                        The pathogenic fungus Cryptococcus neoformans must adapt to glucose-limited co
228                        The pathogenic fungus Cryptococcus neoformans must overcome multiple stressors
229         In previous studies we showed that a Cryptococcus neoformans mutant lacking glucosylceramide
230 of 1201 signature-tagged deletion strains of Cryptococcus neoformans mutants to identify previously u
231 s presenting with P. marneffei (n = 719) and Cryptococcus neoformans (n = 1598) infection to the Hosp
232          CaTOK (Candida albicans) and CnTOK (Cryptococcus neoformans neoformans) pass both K(+) and N
233                     In the pathogenic fungus Cryptococcus neoformans, noncanonical Gbeta Gib2 promote
234                Macrophages ingest the fungus Cryptococcus neoformans only in the presence of opsonins
235 seminated infections with the fungal species Cryptococcus neoformans or, less frequently, Cryptococcu
236                                          The Cryptococcus neoformans polysaccharide capsule is a well
237 xylomannan (GXM), the major component of the Cryptococcus neoformans polysaccharide capsule, hydrolyz
238 b, and IgG3 with a 12-mer peptide mimetic of Cryptococcus neoformans polysaccharide revealed a stoich
239            The opportunistic fungal pathogen Cryptococcus neoformans possesses a polysaccharide capsu
240                        The pathogenic fungus Cryptococcus neoformans produces melanin within its cell
241                        The pathogenic fungus Cryptococcus neoformans produces PGE2, and we found that
242 aride capsule of the human pathogenic fungus Cryptococcus neoformans promotes opsonization but also i
243         Urease, a major virulence factor for Cryptococcus neoformans, promotes lethal meningitis/ence
244 gulatory networks in human pathogens such as Cryptococcus neoformans provides insights into host-path
245    The cell wall of pathogenic fungi such as Cryptococcus neoformans, provides a formidable barrier t
246 on and analysis of SRP in the human pathogen Cryptococcus neoformans, providing the first description
247 he major human opportunistic fungal pathogen Cryptococcus neoformans, remains unknown.
248 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires a T1 adaptive immune re
249 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires the development of T1-t
250            The basidiomycete fungal pathogen Cryptococcus neoformans requires the PUF protein, Pum1,
251  Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans, result in more deaths annually
252 iable tests that discriminate C. gattii from Cryptococcus neoformans (serotypes A, D, and AD).
253  meningoencephalitis-causing fungal pathogen Cryptococcus neoformans, sexual development leads to the
254                                           In Cryptococcus neoformans, sexual reproduction occurs thro
255                            Structurally, the Cryptococcus neoformans Sp1 (Cn Sp1) protein was found t
256 of C57BL/6 mice with the moderately virulent Cryptococcus neoformans strain 52D models the complex ad
257  murine model of C57BL/6J mice infected with Cryptococcus neoformans strain 52D.
258 s in mice given a pulmonary infection with a Cryptococcus neoformans strain engineered to produce the
259 ential of these genes by comparing wild-type Cryptococcus neoformans strain H99 with deletant and com
260  of interferon-gamma transgene expression by Cryptococcus neoformans strain H99gamma in abrogating al
261 yptococcal meningitis patients infected with Cryptococcus neoformans strains with the same multilocus
262 oducibility strains (4 Candida species and 6 Cryptococcus neoformans strains), and 746 isolates of Ca
263 otective immune responses to highly virulent Cryptococcus neoformans strains, such as H99, are associ
264 etrotransposons in the human fungal pathogen Cryptococcus neoformans The resulting DSBs were repaired
265                                              Cryptococcus neoformans, the causative agent of cryptoco
266  pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage organism Zygo
267                 In the human fungal pathogen Cryptococcus neoformans, the homeodomain transcription f
268                                  Finally, in Cryptococcus neoformans, the loss of a cytosine DNA meth
269                                              Cryptococcus neoformans, the most common cause of fungal
270                                              Cryptococcus neoformans, the predominant etiological age
271                 In the human fungal pathogen Cryptococcus neoformans, the Rim101 protein retains cons
272                 In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is im
273  in plants and animals, but in fungi such as Cryptococcus neoformans they are also associated with vi
274                 In the human fungal pathogen Cryptococcus neoformans, three G protein alpha subunits
275 bilities of 110 isolates of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin,
276 nase Ste20, allows the human fungal pathogen Cryptococcus neoformans to grow at high temperature.
277                                 In order for Cryptococcus neoformans to invade the central nervous sy
278 ability of the opportunistic fungal pathogen Cryptococcus neoformans to resist oxidative stress is on
279 rcular (Histoplasma capsulatum) to punctate (Cryptococcus neoformans) to labeling at the bud sites (C
280 ignalling pathways to the basal tolerance of Cryptococcus neoformans towards fluconazole, the widely
281 that in the pathogenic basidiomycetous yeast Cryptococcus neoformans, two Galpha subunits (Gpa2, Gpa3
282                                              Cryptococcus neoformans typically grows in a yeast-like
283                  The human-pathogenic fungus Cryptococcus neoformans undergoes phenotypic switching i
284   Most cases of cryptococcosis are caused by Cryptococcus neoformans var. grubii (serotype A), which
285                                              Cryptococcus neoformans var. grubii is the causative age
286               Compared to other well-studied Cryptococcus neoformans virulence factors such as the po
287                                              Cryptococcus neoformans was first described as a human f
288 cies/organism groups were isolated, of which Cryptococcus neoformans was the most common (31.2% of al
289 the cell wall of the human pathogenic fungus Cryptococcus neoformans We observed that melanin is asse
290                              Using the yeast Cryptococcus neoformans, we describe a mechanism by whic
291 ns, Candida krusei, Candida parapsilosis and Cryptococcus neoformans were investigated.
292 f a human pathogen and basidiomycetous yeast Cryptococcus neoformans were investigated.
293 r understanding Ab-mediated immunity against Cryptococcus neoformans, where the different isotypes ma
294 sis is important for virulence of the fungus Cryptococcus neoformans, which can cause lethal meningoe
295 ypic diversity in the human pathogenic yeast Cryptococcus neoformans, which is globally distributed a
296 fection with environmental organisms such as Cryptococcus neoformans, which require no host in their
297 ave directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infecte
298 ) exhibit potent antifungal activity against Cryptococcus neoformans with high selectivity.
299  of lipid droplets during the interaction of Cryptococcus neoformans with macrophages in the presence
300 vestigated the outcome of the interaction of Cryptococcus neoformans with murine macrophages using la

 
Page Top